Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2018-001418-14Phase 3Active
Phase 3, randomised trial of sildenafil in erectile dysfunction (ED) (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Change in erectile function domain score (IIEF-15). Started May 2021; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2018-001418-14.